[Thrombogenicity of a new prothrombin complex concentrate].
A prothrombin complex concentrate produced according to a new procedure was tested for potential thrombogenicity in vitro and in vivo. The results obtained by in vitro methods (NAPTT, TGt50, determination of the hydrolytic index) were not in the critical range of thrombogenicity. An effective dose of 175 U/kg for thrombus formation assessed in the stasis model of Wessler suggested comparatively low thrombogenicity. In the non stasis model no changes in the haemostaseological variables indicative of consumption reaction were observed after infusion of 125 U/kg for 30 min in rabbits. In the organs investigated (heart, liver, kidneys, adrenals) no thrombin were detected morphologically.